[go: up one dir, main page]

AU5775398A - Site-specific controlled release dosage formulation for mesalamine - Google Patents

Site-specific controlled release dosage formulation for mesalamine

Info

Publication number
AU5775398A
AU5775398A AU57753/98A AU5775398A AU5775398A AU 5775398 A AU5775398 A AU 5775398A AU 57753/98 A AU57753/98 A AU 57753/98A AU 5775398 A AU5775398 A AU 5775398A AU 5775398 A AU5775398 A AU 5775398A
Authority
AU
Australia
Prior art keywords
mesalamine
site
controlled release
release dosage
dosage formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU57753/98A
Inventor
Cesare Busetti
Tiziano Crimella
Vincenzo Olgiati
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Poli Industria Chimica SpA
Original Assignee
Poli Industria Chimica SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Poli Industria Chimica SpA filed Critical Poli Industria Chimica SpA
Publication of AU5775398A publication Critical patent/AU5775398A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU57753/98A 1996-12-17 1997-12-16 Site-specific controlled release dosage formulation for mesalamine Abandoned AU5775398A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US76798096A 1996-12-17 1996-12-17
US08767980 1996-12-17
PCT/IB1997/001652 WO1998026767A2 (en) 1996-12-17 1997-12-16 Site-specific controlled release dosage formulation for mesalamine

Publications (1)

Publication Number Publication Date
AU5775398A true AU5775398A (en) 1998-07-15

Family

ID=25081155

Family Applications (1)

Application Number Title Priority Date Filing Date
AU57753/98A Abandoned AU5775398A (en) 1996-12-17 1997-12-16 Site-specific controlled release dosage formulation for mesalamine

Country Status (2)

Country Link
AU (1) AU5775398A (en)
WO (1) WO1998026767A2 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6733789B1 (en) 1999-01-21 2004-05-11 Biovail Laboratories, Inc. Multiparticulate bisoprolol formulation
US6417227B1 (en) * 1999-04-28 2002-07-09 Cg And Associates Methods of delivery of cetyl myristoleate
ITMI991316A1 (en) * 1999-06-14 2000-12-14 Cip Ninety Two 92 S A ORAL PHARMACEUTICAL COMPOSITIONS WITH MODIFIED RELEASE OF MESALAZINE
EP1210071A1 (en) * 1999-09-06 2002-06-05 Günther Beisel Method for improving and maintaining bowel function as well as a method for the production thereof
CA2359812C (en) 2000-11-20 2004-02-10 The Procter & Gamble Company Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
AR036797A1 (en) 2001-10-15 2004-10-06 Ferring Bv A METHOD TO PREPARE A PHARMACEUTICAL COMPOSITION THAT INCLUDES 5-AMINOSALICILIC ACID TO USE IN THE TREATMENT OF ULCEROSE COLITIS AND CROHN DISEASES
JP2007523664A (en) 2003-04-23 2007-08-23 フェリング ベスローテン フェンノートシャップ Sachet for pharmaceutical composition
EP1547601A1 (en) * 2003-12-23 2005-06-29 Ferring B.V. Coating method
WO2009047801A1 (en) * 2007-10-10 2009-04-16 Lupin Limited Therapeutic combinations and compositions for the treatment of gastrointestinal disorders
US20110311631A1 (en) * 2009-03-18 2011-12-22 Evonik Röhm Gmbh Controlled release pharmaceutical composition with resistance against the influence of ethanol employing a coating comprising a polymer mixture and excipients
US9463163B2 (en) * 2009-10-16 2016-10-11 Sun Pharmaceutical Industries Limited Delayed release pharmaceutical composition of mesalamine
EP2425826A1 (en) * 2010-09-01 2012-03-07 Disphar International B.V. Mesalazine tablet having improved dissolution
US20140105956A1 (en) * 2012-10-11 2014-04-17 Rupak BANERJEE Biodegradable polymer based microimplant for ocular drug delivery
IN2014MU00097A (en) * 2014-01-10 2015-08-21 Cadila Healthcare Ltd
ITUA20162293A1 (en) 2016-04-05 2017-10-05 Sofar Spa Process for solid formulations of mesalazine
TR201722039A2 (en) * 2017-12-27 2019-07-22 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi SOLID ORAL PHARMACEUTICAL COMPOSITIONS OF MESALAZINE
EP3662895A1 (en) 2018-12-07 2020-06-10 Tillotts Pharma AG A process for manufacturing reducing sugar-free 5-asa tablet cores
IT201900018041A1 (en) 2019-10-07 2021-04-07 Sara Pellegrino POLYETHYLENIMMIN WITH N-ACYLATE HYDROXYPYRIDONIC FUNCTION, THEIR SYNTHESIS AND THERAPEUTIC USE
WO2022066110A1 (en) * 2020-09-25 2022-03-31 Pharmacti̇ve İlaç Sanayi̇ Ve Ti̇caret A.Ş. Pharmaceutical compositions comprising mesalamin and relevant excipients

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1246382B (en) * 1990-04-17 1994-11-18 Eurand Int METHOD FOR THE TARGETED AND CONTROLLED DELIVERY OF DRUGS IN THE INTESTINE AND PARTICULARLY IN THE COLON
BR9106419A (en) * 1990-05-04 1993-05-04 Perio Prod Ltd COLONIC MEDICATION RELEASE SYSTEM
IE61651B1 (en) * 1990-07-04 1994-11-16 Zambon Spa Programmed release oral solid pharmaceutical dosage form
JPH07223970A (en) * 1994-02-10 1995-08-22 Tanabe Seiyaku Co Ltd Release product in place in digestive tract
US5482718A (en) * 1994-03-23 1996-01-09 Hoffmann-La Roche Inc. Colon-targeted delivery system
ATE357221T1 (en) * 1994-04-22 2007-04-15 Astellas Pharma Inc COLON-SPECIFIC DRUG RELEASE SYSTEM

Also Published As

Publication number Publication date
WO1998026767A2 (en) 1998-06-25
WO1998026767A3 (en) 1998-09-03

Similar Documents

Publication Publication Date Title
IL121275A (en) Controlled release formulation for poorly soluble basic drugs
AU5775398A (en) Site-specific controlled release dosage formulation for mesalamine
AU1640097A (en) Extended release formulation
AU3995797A (en) Controlled release formulation
AU1806895A (en) Controlled release composition
AU3406497A (en) Controlled release tablet
AU2746992A (en) Controlled release pharmaceutical compositions
AU3854295A (en) Sustained release caffeine formulation
AU3977099A (en) Controlled release oral dosage form
AU4256996A (en) Parasiticide formulations suitable for dermal application
EG23934A (en) Poroxetine controlled release compositions
GB9826662D0 (en) Controlled release formulation
AU5200098A (en) Sustained release formulation containing dfmo
AU6593498A (en) Controlled release compositions
AU3066995A (en) Anion releasing apparatus for video appliances
AU3352297A (en) Controlled release tablets
AU4233997A (en) Process for preparing pharmaceutical compounds
AU4552797A (en) Spacing device for spreading stamped material
AU2160095A (en) Quick release receptacle
AU3333997A (en) Device for eliminating deviation
GB9404544D0 (en) Controlled release formulation
AU5049098A (en) Pharmaceutical formulation
AU3749595A (en) Method for preparing controlled release pharmaceutical forms
AU3002595A (en) Controlled release fertilizers
AU7799198A (en) Method for preparing pharmaceutical formulation